Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CAMK1D | Q8IU85 | 20/20 | 0.53 |
| ▸ | RIPK4 | P57078 | 2/20 | 0.50 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.50 |
| ▸ | MAP2K5 | Q13163 | 2/20 | 0.50 |
| ▸ | MAP3K11 | Q16584 | 2/20 | 0.50 |
| ▸ | PIP5K1C | O60331 | 1/20 | 0.50 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | CAMK1 | Q14012 | 1/20 | 0.50 |
| ▸ | PNCK | Q6P2M8 | 1/20 | 0.50 |
| ▸ | CAMK1G | Q96NX5 | 1/20 | 0.50 |
| ▸ | MAP3K7 | O43318 | 1/20 | 0.47 |
| ▸ | CSF1R | P07333 | 1/20 | 0.47 |
| ▸ | PIM1 | P11309 | 1/20 | 0.47 |
| ▸ | MAPK3 | P27361 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | SYK | P43405 | 1/20 | 0.47 |
| ▸ | BLK | P51451 | 1/20 | 0.47 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.47 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30416706 | 0.87 | HDAC6 (0.53) | CAMK1DRIPK4KCNH2MAP2K5MAP3K11 | |
| SCHEMBL20917117 | 0.81 | POLB (0.50) | — | |
| SCHEMBL4790004 | 0.79 | POLB (0.49) | — | |
| SCHEMBL30422887 | 0.79 | HRH3 (0.47) | CAMK1D | |
| SCHEMBL2413103 | 0.79 | POLB (0.54) | CAMK1DRIPK4KCNH2MAP2K5MAP3K11 | |
| SCHEMBL1027517 | 0.78 | CAMK1D (0.43) | CAMK1DRIPK4KCNH2MAP2K5MAP3K11 | |
| SCHEMBL1027516 | 0.78 | CAMK1D (0.43) | CAMK1DRIPK4KCNH2MAP2K5MAP3K11 | |
| SCHEMBL30165801 | 0.76 | JAK3 (0.54) | — | |
| SCHEMBL30165821 | 0.76 | JAK3 (0.54) | — | |
| SCHEMBL26684586 | 0.74 | HRH3 (0.44) | CAMK1DRIPK4KCNH2MAP2K5MAP3K11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11530193-B2 | Kinase inhibitors | THE UNIVERSITY OF MANCHESTER (GB) | 2022-12-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11530193-B2 | Kinase inhibitors | CAMKK2, CAMK1, CAMKK1 | CAMK1D 5/4885RIPK4 266/4885KCNH2 2708/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.